Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Xpress™ Human TRPM7 Over-expressing Stable Cell Line

AcceGen can provide custom lentiviral constructs expressing any genes of interest as long as it is less than about 3 kb. Lentiviral technology enables us to efficiently generate stable expression lines which are then selected for moderate or high expressers, depending on the experimental requirements. If you are interested in specific lentiviral DNA constructs or have further questions, please contact us to discuss the details. TRPM7 transient receptor potential cation channel, subfamily M, member 7 [ Homo sapiens ] http://www.ncbi.nlm.nih.gov/gene/54822

Product Specifications

Applications

For research use only

Storage Conditions

Liquid Nitrogen

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

ZNF365 (NM_014951) Human Over-expression Lysate
LS022891 100 µg

ZNF365 (NM_014951) Human Over-expression Lysate

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-01 0.02 mg (With BSA & Azide at 0.2mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-02 0.1 mg (With BSA & Azide at 0.2mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-03 0.1 mg (Without BSA & Azide at 1mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details
PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)
MBS4380958-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)

PD-L1/PDCD1LG1/CD274/B7-H1 (Cancer Immunotherapy Target)

Ask
View Details